Encyclopedia

  • Thiol containing compounds and amino acid hydroxamates as reversible synthetic inhibitors of Astacus protease☆
  • Add time:09/06/2019         Source:sciencedirect.com

    Reversible synthetic inhibitors are characterized for Astacus protease, a 22,614-Da zinc containing neutral endopeptidase from the digestive tract of crayfish. Effective inhibition was demonstrated for several simple thiol containing compounds and a series of amino acid hydroxamates. Both classes of inhibitors had ID50 values ranging from 10−2 to 10−4m for inhibition of hydrolysis of succinylAlaAlaAlap-nitroanilide. Tyrosine hydroxamate was found to be the most effective inhibitor with an ID50 of 175 μm and the mode of inhibition by this compound was determined to be of the simple noncompetitive type. In contrast to the other inhibitors tested, cysteine was seen to partially inactivate the enzyme in a time-dependent manner. The kinetics of this process was studied in detail using progress curve analysis. It was determined that cysteine was acting as a weak chelator and slowly establishing an equilibrium between metallo- and apoenzyme. In the presence of the strong zinc scavenger EDTA, cysteine can, in effect, function as a catalyst in transferring the metal from the protein to the secondary chelator at a rate 10,000 times faster than the rate of unassisted zinc dissociation. The series of amino acid hydroxamates served as probes into the microenvironment of the active site. Possible binding modes of the inhibitors are discussed on the basis of the relationship between the chemical nature of the inhibitor side chains and the strength of inhibition.

    We also recommend Trading Suppliers and Manufacturers of DL-ALANINE HYDROXAMATE (cas 16707-85-0). Pls Click Website Link as below: cas 16707-85-0 suppliers


    Prev:Studies on the syntheses of heterocycles from 3-arylsydnone-4-carbohydroximic acid chlorides with N-arylmaleimides, [1,4]naphthoquinone and aromatic amines
    Next: The isolation and identification of 2-methyl-2,4-thiazolidine dicarboxylate (cas 16708-09-1) as a by-product in the conversion of cysteine to glucose in the perfused rat liver)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View